Back to search

Pyramid Pharma 7 Ltd

13467502

active
ltd
england wales
Companies House
Accounts overdue
Health Score
66 / 100

Some Concerns

10/30
Filing
20/30
Financial
36/40
Risk
  • Accounts filing overdue (-15)
  • No accounts filed in last 18 months (-5)
  • 2 outstanding charges (-4)

Details

C/O Ask Accountants The Grainger Suite, Dobson House, Regent Farm Road, Newcastle Upon Tyne, NE3 3PF
Incorporated 21/06/2021

Compliance

Last accounts

30/06/2024

unaudited abridged

Next accounts due

18/06/2026

Overdue

Confirmation statement

Last: 21/02/2026

Due 07/03/2027

On track

Industry

47730
Dispensing chemist in specialised stores

Officers

Mr Xavier Scipioni-Qureshi

director · Since 31/01/2022

DIRECTOR

BRITISH · UNITED KINGDOM · Age 34

Ms Boon Mean Tan

director · Since 31/01/2022

DIRECTOR

MALAYSIAN · UNITED KINGDOM · Age 35

Also on 1 other board

Xavier Scipioni-Qureshi

director · Since 31/01/2022

British · United Kingdom · Age 34

Boon Mean Tan

director · Since 31/01/2022

Malaysian · United Kingdom · Age 35

Former

Jagjeet Singh Bhogal

director · Resigned 31/01/2022

Persons with Significant Control

Mx1 Limited

75–100% shares
75–100% votes
Appoint directors

C/O Ask Accountants, The Grainger Suite, Dobson House, Newcastle Upon Tyne, NE3 3PF

Reg: 13470992 · England And Wales · Private Limited Company

Notified 31/01/2022

Former PSCs

Pyramid Pharma Pharmaceuticals Limited

Ceased 31/01/2022

Charges2 outstanding

Charge
outstanding

BARCLAYS SECURITY TRUSTEE LIMITED

Created 16/10/2023Registered 16/10/2023
Charge
outstanding

BARCLAYS SECURITY TRUSTEE LIMITED

Created 02/10/2023Registered 03/10/2023

Change History

statusactive
2026-07-14

Active

typeltd
2026-07-14

Private Limited Company

address line1C/O Ask Accountants The Grainger Suite, Dobson House
2026-07-14

C/O ASK ACCOUNTANTS THE GRAINGER SUITE, DOBSON HOUSE

post townNewcastle Upon Tyne
2026-07-14

NEWCASTLE UPON TYNE

CompanyRankvs 1862+ SIC 47730 peers
54

Financial strength86th percentile among SIC peers · 22/25
Employees78th percentile among SIC peers · 12/15
LiquidityCurrent ratio 3.36× · 20/20
Longevity5 years trading (max 15) · 5/15
Filing complianceOne filing overdue · 5/15
Outstanding charges -10
Show leaderboard
How is this score calculated?
Financial strength22/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees12/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity5/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance5/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Outstanding charges: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 30/06/2024

Net Worth

£635k

Balance sheet strength

Cash

£95k

Cash in the bank

Net Current Assets

£545k

Working capital

Current Assets

£777k

Current Liabilities

£231k

Fixed Assets

£254k

Debtors

£594k

10avg. employees+5

Balance Sheet

Assets less current liabilities£799k
Signed by Mr Xavier Scipioni-Qureshi 31 March 2025Prepared with Acorah Software Products - Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
20243.36+£89k
20236.88

Derived from filed accounts. Not audited figures.